With a mission to improve lives through substance abuse counseling solutions, Pelago is a company that offers a virtual health clinic. The company offers its virtual care by partnering with healthcare payors at enterprises to provide counseling services to employees. Pelago was formerly known as Quit Genius and was founded in 2017 by Maroof Ahmed, Yusuf Sherwani, and Sarim Siddiqui and is headquartered in New York, NY. Pelago offers a wide range of substance abuse support services including cognitive behavioral therapy and medication-assisted treatment as well as preventive education, primarily for tobacco, alcohol, and opioid abuse.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/28/2024 | Series C | $58MM | $xx.xx | $349.85MM | Atomico, Kinnevik AB, Octopus Ventures, Y Combinator, Eight Roads, GreyMatter Capital | |
Price per Share
$xx.xx
Shares Outstanding
3,304,730
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Atomico, Kinnevik AB, Octopus Ventures, Y Combinator, Eight Roads, GreyMatter Capital
|
||||||
07/19/2021 | Series B | $66.01MM | $xx.xx | $243.91MM | Kinnevik, Atomico, Octopus Ventures, Triple Point Ventures, Startup Health | |
Price per Share
$xx.xx
Shares Outstanding
3,977,733
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Kinnevik, Atomico, Octopus Ventures, Triple Point Ventures, Startup Health
|
||||||
03/19/2020 | Series A-6 | $321,994 | $xx.xx | $53.31MM | Octopus Ventures, Triple Point Ventures, Startup Health | |
Price per Share
$xx.xx
Shares Outstanding
210,688
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Octopus Ventures, Triple Point Ventures, Startup Health
|
||||||
03/19/2020 | Series A-5 | $179,999 | $xx.xx | $53.31MM | Octopus Ventures, Triple Point Ventures, Startup Health | |
Price per Share
$xx.xx
Shares Outstanding
113,067
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Octopus Ventures, Triple Point Ventures, Startup Health
|
||||||
03/19/2020 | Series A-4 | $599,989 | $xx.xx | $53.31MM | Octopus Ventures, Triple Point Ventures, Startup Health | |
Price per Share
$xx.xx
Shares Outstanding
314,070
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Octopus Ventures, Triple Point Ventures, Startup Health
|
||||||
03/19/2020 | Series A-3 | $482,991 | $xx.xx | $53.31MM | Octopus Ventures, Triple Point Ventures, Startup Health | |
Price per Share
$xx.xx
Shares Outstanding
210,689
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Octopus Ventures, Triple Point Ventures, Startup Health
|
||||||
03/19/2020 | Series A-2 | $124,996 | $xx.xx | $53.31MM | Octopus Ventures, Triple Point Ventures, Startup Health | |
Price per Share
$xx.xx
Shares Outstanding
49,073
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Octopus Ventures, Triple Point Ventures, Startup Health
|
||||||
03/19/2020 | Series A-1 | $12MM | $xx.xx | $53.31MM | Octopus Ventures, Triple Point Ventures, Startup Health | |
Price per Share
$xx.xx
Shares Outstanding
2,696,630
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Octopus Ventures, Triple Point Ventures, Startup Health
|